🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning properties. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting substances of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment.

Platform Response and Material Elimination

Based on the social media company, the platform has taken down violative content and banned associated hashtags and query recommendations. The organization said it was committed to maintaining the service safe and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, filled with photos of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at residence.

After minutes of entering one community, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Details and Costs

Within these communities, posts display dark colored packages with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how long a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A representative for Telegram said it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they cannot confirm. Although the research behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has previously seen patients injured by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your health,” said the doctor. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject users to possibly significant health risks”.